Roche launches comprehensive genomic profiling kit

The AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science.

Patients Must Be Warned of Breast Implant Risks, FDA Says

A decade after scientists identified a link between certain implants and cancer, the US Food and Drug Administration (FDA) has ordered “black box” warnings and a new checklist of risks for patients to review.

Carbon nanotube-based sensor can detect SARS-CoV-2 proteins

Researchers from the Massachusetts Institute of Technology (MIT) in the US have developed a new sensor to detect SARS-CoV-2 proteins without antibodies. The new sensor eliminates the need to send the sample to a lab for analysis using antibodies or other reagents and provides results within five minutes.

Genentech’s new treatment for wet AMD receives FDA approval

Genentech has received approval from the US FDA for Susvimo, the first wet, or neovascular, AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month.